Osteopore (OSX) is a Singapore headquartered corporation strategically poised to be a leading medical device company in the region.
Osteopore started with a hope to change the lives of many by making bone regrowth scalable.
In 1996, a team of researchers (Osteopore’s early founders) were inspired after seeing a body part successfully recreated outside of the body and implanted for regeneration. They started looking into a scaffold design that would, later on, embody the principle of Tissue Engineering and Regenerative Medicine, with 3D printer as the enabler.
Over two decades later, Osteopore’s implants are being used worldwide to regrow bones whilst reducing post-surgical complications. Osteopore’s implants have proven surgical outcomes in applications across Asia, Europe, Australia, and the Americas.